Table 1.
Demographic and clinical characteristics for the patient and control groups
| Patients (n = 14) | Controls (n = 14) | P | |
| Demographic measures | Mean/SD | Mean/SD | |
| Age (years/SD) | 13.4/2.6 | 13.5/2.8 | NS |
| Sex (M/F) | 12/2 | 12/2 | NS |
| Parental SES | 40.4 (10.2) | 53.7 (7.4) | 0.0007 |
| Clinical measures | |||
| Psychotic symptoms (mean/SD) | 2.5/1.2 | ||
| Negative symptoms (mean/SD) | 2.6/0.8 | ||
| Disorganized symptoms (mean/SD) | 2.0/1.2 | ||
| Antipsychotic medications | Number | Mean dose | |
| Aripiprazole | 3 | 23.3 | |
| Ziprasidone | 2 | 40 | |
| Risperidone | 3 | 3.2 | |
| Quetiapine | 2 | 250 | |
| None | 2 |
NS, not significant.